PRLD · Prelude Therapeutics Inc · Proposed Sales
$3.88
+0.18 (+4.86%)
At close · Oct 27
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Market Cap
$295.27M
Shares
79.80M
Volume · Oct 27
277.22K
Avg daily vol (3M)
518.04K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.